REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 8,308 | +274.1% | 0.00% | – |
| Q3 2022 | $1,000 | -90.0% | 2,221 | -80.8% | 0.00% | – |
| Q2 2022 | $10,000 | -56.5% | 11,592 | +25.5% | 0.00% | – |
| Q1 2022 | $23,000 | -81.5% | 9,233 | -80.9% | 0.00% | – |
| Q4 2021 | $124,000 | -35.8% | 48,351 | +78.2% | 0.00% | – |
| Q3 2021 | $193,000 | +1.6% | 27,132 | -2.2% | 0.00% | – |
| Q2 2021 | $190,000 | – | 27,732 | +127.1% | 0.00% | – |
| Q4 2020 | $0 | – | 12,213 | -20.3% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 15,317 | -54.3% | 0.00% | – |
| Q2 2020 | $224,000 | +64.7% | 33,545 | +11.7% | 0.00% | – |
| Q1 2020 | $136,000 | -3.5% | 30,027 | +28.8% | 0.00% | – |
| Q4 2019 | $141,000 | +14000.0% | 23,320 | +11618.6% | 0.00% | – |
| Q3 2018 | $1,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 367,346 | $926,000 | 0.15% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,950,002 | $4,914,000 | 0.11% |
| Claret Asset Management Corp | 95,430 | $240,000 | 0.05% |
| Annandale Capital, LLC | 43,532 | $110,000 | 0.04% |
| ARK Investment Management | 861,798 | $2,172,000 | 0.01% |
| Virtu Financial LLC | 26,864 | $68,000 | 0.01% |
| Ancora Advisors LLC | 82,048 | $207,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 4,600 | $1,372,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 25,499 | $64,000 | 0.00% |
| ATTICUS WEALTH MANAGEMENT, LLC | 2,425 | $6,000 | 0.00% |